Callan Family Office’s Haleon HLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.59M Sell
705,978
-28,592
-4% -$266K 0.13% 157
2026
Q1
$7.35M Sell
734,570
-4,079
-0.6% -$42.4K 0.17% 123
2025
Q4
$7.47M Buy
738,649
+67,677
+10% +$643K 0.16% 126
2025
Q3
$6.02M Sell
670,972
-88,552
-12% -$853K 0.19% 121
2025
Q2
$7.88M Buy
759,524
+550,711
+264% +$5.81M 0.25% 85
2025
Q1
$2.15M Buy
208,813
+2,314
+1% +$22.8K 0.16% 122
2024
Q4
$1.97M Buy
+206,499
New +$2.02M 0.13% 153
2023
Q2
– Sell
-41,900
Closed -$341K – 134
2023
Q1
$341K Buy
+41,900
New +$334K 0.08% 125

Other funds holding HLN

Callan Family Office's HLN Position: Q2 2026 in Review

Callan Family Office reduced its Haleon (HLN) stake by 3.9% in Q2 2026, selling an estimated $266K and leaving 705,978 shares worth $6.59M. The position accounts for 0.13% of the portfolio, ranked #157.

Callan Family Office first reported a position in HLN in Q1 2023 and has held it in 8 quarters since. The position peaked at $7.88M in Q2 2025. 646 funds tracked by Wall St. Rank hold HLN as of Q2 2026.

  • Callan Family Office held 705,978 shares of Haleon worth $6.59M as of Q2 2026.
  • Callan Family Office sold 28,592 Haleon shares in Q2 2026, an estimated $266K.
  • Haleon made up 0.13% of Callan Family Office's portfolio in Q2 2026, its #157 holding.
  • Callan Family Office first reported a position in Haleon in Q1 2023 and has held it in 8 quarters since.
  • Callan Family Office's Haleon position peaked at $7.88M in Q2 2025.
  • 646 funds tracked by Wall St. Rank held Haleon as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.